Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
November 9, 2022
Design and Synthesis of Ubiquitin-Based Chemical Tools with Unnatural Amino Acids for Selective Detection of Deubiquitinases
Wioletta Rut, Mikolaj Zmudzinski, Marcin Drag
Current Opinion in Chemical Biology
|
April 9, 2023
Imaging of proteases using activity-based probes
Mikolaj Zmudzinski, Oliwia Malon, Marcin Poręba, et al.
Chemical Science
|
September 21, 2020
Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes
Wioletta Rut, Mikolaj Zmudzinski, Scott J Snipas, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
<i>Reynoutria</i> Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study
Izabela Nawrot-Hadzik, Mikolaj Zmudzinski, Adam Matkowski, et al.
RSC Chemical Biology
|
June 16, 2025
Correction: Proximity-induced SuFEx increases the potency of cytosolic nucleotidase inhibitors and reveals a rare example of covalently targeted histidine
Mikolaj Chrominski, Marcin Warminski, Mateusz Kozarski, et al.
RSC Chemical Biology
|
May 1, 2025
Proximity-induced SuFEx increases the potency of cytosolic nucleotidase inhibitors and reveals a rare example of covalently targeted histidine
Mikolaj Chrominski, Marcin Warminski, Mateusz Kozarski, et al.
Plos Computational Biology
|
November 21, 2022
Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug binding
Agata P Perlinska, Adam Stasiulewicz, Mai Lan Nguyen, et al.
Nature Chemical Biology
|
October 23, 2020
SARS-CoV-2 M<sup>pro</sup> inhibitors and activity-based probes for patient-sample imaging
Wioletta Rut, Katarzyna Groborz, Linlin Zhang, et al.
Science Advances
|
October 17, 2020
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design
Wioletta Rut, Zongyang Lv, Mikolaj Zmudzinski, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design
Wioletta Rut, Zongyang Lv, Mikolaj Zmudzinski, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
November 9, 2022
Design and Synthesis of Ubiquitin-Based Chemical Tools with Unnatural Amino Acids for Selective Detection of Deubiquitinases
Wioletta Rut, Mikolaj Zmudzinski, Marcin Drag
Current Opinion in Chemical Biology
|
April 9, 2023
Imaging of proteases using activity-based probes
Mikolaj Zmudzinski, Oliwia Malon, Marcin Poręba, et al.
Chemical Science
|
September 21, 2020
Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes
Wioletta Rut, Mikolaj Zmudzinski, Scott J Snipas, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
<i>Reynoutria</i> Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study
Izabela Nawrot-Hadzik, Mikolaj Zmudzinski, Adam Matkowski, et al.
RSC Chemical Biology
|
June 16, 2025
Correction: Proximity-induced SuFEx increases the potency of cytosolic nucleotidase inhibitors and reveals a rare example of covalently targeted histidine
Mikolaj Chrominski, Marcin Warminski, Mateusz Kozarski, et al.
RSC Chemical Biology
|
May 1, 2025
Proximity-induced SuFEx increases the potency of cytosolic nucleotidase inhibitors and reveals a rare example of covalently targeted histidine
Mikolaj Chrominski, Marcin Warminski, Mateusz Kozarski, et al.
Plos Computational Biology
|
November 21, 2022
Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug binding
Agata P Perlinska, Adam Stasiulewicz, Mai Lan Nguyen, et al.
Nature Chemical Biology
|
October 23, 2020
SARS-CoV-2 M<sup>pro</sup> inhibitors and activity-based probes for patient-sample imaging
Wioletta Rut, Katarzyna Groborz, Linlin Zhang, et al.
Science Advances
|
October 17, 2020
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design
Wioletta Rut, Zongyang Lv, Mikolaj Zmudzinski, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design
Wioletta Rut, Zongyang Lv, Mikolaj Zmudzinski, et al.
Page
of 2